Search
for

    Did you mean Androgen Suppression?
    Glossary Androgen Suppression

    reducing or blocking male hormones to slow cancer growth

    Androgen Suppression, also known as Androgen Deprivation Therapy (ADT), involves reducing or blocking the action of androgens (male hormones like testosterone) to slow the growth of certain cancers, such as prostate cancer. This can be achieved through medications that inhibit androgen production or through surgical procedures like orchiectomy (removal of the testes).

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Sex differences in COVID-19: the role of androgens in disease severity and progression Endocrine · 2020 · 121 citations
    2. The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response Fertility and sterility · 1994 · 23 citations
    3. Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor Frontiers in Bioengineering and Biotechnology · 2022
    4. Diagnosis and treatments of hirsutism: where are we? Expert Review of Dermatology · 2011 · 3 citations
    5. Hair Loss in Women Seminars in Cutaneous Medicine and Surgery · 2009 · 81 citations
    6. Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications JCEM case reports · 2023 · 1 citations
    7. <i>Arachis hypogaea</i> L. Root Extract Mitigates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in ICR Mice by Suppressing Inflammation, Androgen Receptors, and Dihydrotestosterone Food Science & Nutrition · 2026
    8. Treatment of androgenic disorders in women: acne, hirsutism, and alopecia Cleveland Clinic journal of medicine · 1990 · 19 citations
    9. Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach DOAJ (DOAJ: Directory of Open Access Journals) · 2017
    10. Androgens/Androgen Receptor in the Management of Skin Diseases Journal of Biosciences and Medicines · 2022 · 1 citations
    11. Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies Expert Opinion on Drug Safety · 2018
    12. Androgenic disorders of women: Diagnostic and therapeutic decision making The American Journal of Medicine · 1995 · 17 citations
    13. Identification of Androgen-Inducible TGF-β1 Derived from Dermal Papilla Cells as a Key Mediator in Androgenetic Alopecia Journal of Investigative Dermatology Symposium Proceedings · 2003 · 78 citations
    14. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis Clinical Endocrinology · 2017 · 20 citations
    15. A new way to restore tumour suppressor function Nature Reviews Drug Discovery · 2013
    16. Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1 The Journal of Clinical Endocrinology and Metabolism · 1998 · 14 citations
    17. 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES European Urology Supplements · 2011
    18. Androgenic Alopecia Dermatologic Clinics · 1987 · 14 citations
    19. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    20. Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer Journal of Agricultural and Food Chemistry · 2013 · 11 citations
    21. Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise Endocrinology · 2004 · 28 citations
    22. Emerging pharmacotherapies for Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2026
    23. The investigation and management of the hirsute woman Reviews in gynaecological and perinatal practice · 2006 · 1 citations
    24. Recent advances in the treatment of polycystic ovary syndrome Expert Opinion on Investigational Drugs · 2004 · 12 citations
    25. The Evaluation and Management of Hirsutism 2003 · 11 citations
    26. The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia International Journal of Biological Sciences · 2023 · 2 citations
    27. DKK3–CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia Theranostics · 2026
    28. Spironolactone and XPB: An Old Drug with a New Molecular Target Biomolecules · 2020 · 18 citations
    29. Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells Therapeutics · 2025
    30. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla Journal of Dermatological Science · 2010 · 122 citations